跳转至内容
Merck
CN

D4268

NG,NG-二甲基精氨酸 二盐酸盐

≥98% (TLC), powder, NOS inhibitor

别名:

不对称-二甲基精氨酸, ADMA

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C8H18N4O2 · 2HCl
化学文摘社编号:
分子量:
275.18
UNSPSC Code:
12352209
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (TLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

NG,NG-二甲基精氨酸 二盐酸盐,

assay

≥98% (TLC)

Quality Level

form

powder

solubility

water: 50 mg/mL, clear, colorless

storage temp.

room temp

SMILES string

Cl[H].Cl[H].CN(C)C(=N)NCCC[C@H](N)C(O)=O

InChI

1S/C8H18N4O2.2ClH/c1-12(2)8(10)11-5-3-4-6(9)7(13)14;;/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14);2*1H/t6-;;/m0../s1

InChI key

SYLNVYJOPZWPJI-ILKKLZGPSA-N

General description

N G N G -二甲基精氨酸二盐酸盐是一种甲基化精氨酸衍生物,由肝脏产生。与肝硬化、酒精性肝炎和急性肝衰竭 (ALF) 有关。

Application

NG,NG-二甲基精氨酸二盐酸盐曾被用于:
  • 研究其对大鼠头端延髓腹外侧区(RVLM) 心血管活动的影响
  • ,作为测量L-精氨酸和二甲基精氨酸的标准
  • 来研究其对肝脏恶化的影响

Biochem/physiol Actions

体内和体外可逆的一氧化氮合成酶抑制剂。


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

DISCOVER Bioactive Small Molecules for Nitric Oxide & Cell Stress Research


José D Martins et al.
Journal of the American Heart Association, 8(7), e011536-e011536 (2019-04-02)
Background Optimally treated patients with coarctation of the aorta remain at risk for late vascular dysfunction. The effect of treatment modality on vascular function is unknown. The LOVE-COARCT (Long-term Outcomes and Vascular Evaluation After Successful Coarctation of the Aorta Treatment)
Kyoung Min Kim et al.
Cardiovascular diabetology, 16(1), 146-146 (2017-11-11)
The cardiovascular benefits of statins have been proven, but their effect on circulation in small vessels has not been examined fully. We investigated the effect of 20 mg rosuvastatin on biomarkers, including paraoxonase-1 (PON-1) and asymmetric dimethylarginine (ADMA), and on microvascular
Marie Rodling Wahlström et al.
SpringerPlus, 3, 98-98 (2014-03-07)
A prospective, randomised, double-blinded, clinical trial was performed at a level 1 trauma centre to determine if a prostacyclin analogue, epoprostenol (Flolan®), could attenuate systemic inflammatory response in patients with severe traumatic brain injury (TBI). 46 patients with severe TBI



全球贸易项目编号

货号GTIN
D4268-50MG04061833564233
D4268-10MG04061833564226